Sign In
Buy CAI
$15.67
-0.420 (-2.61%)
At Close: Jul 31, 2026
Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, April 8, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, n
Ultra-deep Whole Genome and Transcriptome Sequencing provides a more complete workup for myeloid malignancies with clearer, faster diagnostic insight IRVING, Texas, April 2, 2026 /PRNewswire/ -- Cari
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
06:00pm, Tuesday, 31'st Mar 2026
Results demonstrate the superiority of Whole Genome Sequencing compared to methylation-based approaches IRVING, Texas, March 31, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, p
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer
08:30am, Thursday, 26'th Mar 2026
Caris AI Insights are proprietary algorithms only available to Caris Life Sciences customers and not achievable through small panels IRVING, Texas, March 26, 2026 /PRNewswire/ -- Caris Life Sciences�
Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026
08:30am, Wednesday, 25'th Mar 2026
IRVING, Texas, March 25, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced tha
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month
08:30am, Tuesday, 24'th Mar 2026
Caris reinforces the value of Whole Exome Sequencing and Whole Transcriptome Sequencing testing for cancer patients IRVING, Texas, March 24, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI),
Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
08:30am, Friday, 20'th Mar 2026
Highlighting the critical role of Caris GPSai in improving cancer care IRVING, Texas, March 20, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI
Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer
08:30am, Monday, 16'th Mar 2026
Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, March 16, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric,
Caris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual Meeting
08:30am, Wednesday, 11'th Mar 2026
IRVING, Texas, March 11, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that
Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, March 9, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, ne
Concordia Named CAI‑NJ Community of the Year; Community Manager Earns Statewide Honor
09:00am, Wednesday, 04'th Mar 2026
EATONTOWN, N.J., March 4, 2026 /PRNewswire/ -- FirstService Residential, North America's leading residential community management company, received two prestigious honors from the Community Associati
BTSG vs. CAI: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 03'rd Mar 2026
Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. (BTSG) and Caris Life Sciences,?Inc. (CAI). But which of these two stocks presents
Caris Life Sciences (NASDAQ:CAI) Shares Gap Up After Better-Than-Expected Earnings
02:48am, Saturday, 28'th Feb 2026
Caris Life Sciences, Inc. (NASDAQ: CAI - Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $19.24, but op
Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript
11:37am, Friday, 27'th Feb 2026
Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript
These Analysts Revise Their Forecasts On Caris Life Sciences Following Q4 Earnings
08:55am, Friday, 27'th Feb 2026
Caris Life Sciences Inc. (NASDAQ: CAI) on Thursday posted better-than-expected fourth-quarter earnings.
